Share on Google Plus Share on Twitter Share on Facebook Share on LinkedIn Share on PInterest Share on Fark! Share on Reddit Share on StumbleUpon Tell A Friend

Printer Friendly Page Save As Favorite View Favorites   No comments
Exclusive to Futurehealth:
Articles

The Price of ADHD Business

By       Message Frank J. Granett R.ph.     Permalink
      (Page 1 of 1 pages)
Related Topic(s): ; ; ; ; ; ; ; ; ; ; (more...) , Add Tags  (less...) Add to My Group(s)

View Ratings | Rate It

futurehealth.org Headlined to H2 4/26/14

Author 2870
 

The Price of ADHD Business 

By Frank J. Granett R.ph.

Over 12 million children and young adults consume ADHD stimulant and psychiatric medications in the United States.   Pharmaceutical corporations generated over 10 billion dollars in 2013 for ADHD stimulant drug sales, representing five times the 1.7 billion in sales ten years ago.   More alarming, this rate of consumption represents 3x the world's children combined, according to data collected by Scientific American.   The   business model of behaviorally assessing and prematurely medicating  young school age children with powerful stimulant and psychoactive drug therapy for over 40 years is now under fire.   The Government  Accountability Office (GAO) Child Foster Care Drug Audit Report uncovered dangerous and unethical prescribing practices.   Widespread abuses of overmedicating   young foster care children with ADHD stimulant as well as psychiatric medications prior to ruling out nutritional, physiological and environmental risk factors were uncovered by the largest child foster care   prescription drug audit in American history.

In today's America, parents, educators and prominent healthcare professionals challenge the 40-year ADHD business model, as the ADHD diagnosis rate will reach epidemic status in 2014.  The symptoms of ADHD are real and in many cases can be debilitating to children as well as adults.   Especially in the young child population, the ADHD business model of assessment and treatment requires immediate reform.   Children have a right to receive comprehensive bio-assessments as well    as behavioral assessments to determine cause of their symptoms prior to powerful stimulant and psychoactive drug therapy.

The Diagnostic and Statistical Manual for Mental disorders (DSM) lists   ADHD as a mental disorder.  The DSM diagnosing criteria, created by psychiatrists, involves a subjective behavioral assessment process which forces children primarily into premature drug therapy.  Although seven out of ten children may exhibit an initial positive behavioral response to stimulant drug therapy for focus and attention, the long term side effects  are now known.   The Johns Hopkins Child Center Study results of 2013 prove that stimulant drug therapy should not be the primary intervention   in young children.   This study followed four year old preschool children who were diagnosed by their physicians for ADHD and medicated with stimulant drug therapy for a six year period.   When the ADHD assessments were reviewed at age ten, over ninety percent of the children were worse off in their condition.   Long term side effects of ADHD stimulants may include anxiety, minor depression as well as aggressive behavior.   Additionally,   the Hopkins study determined that ADHD causes an economic burden to   the US economy exceeding 45 billion dollars, annually.     

Many parents are not aware that a diagnosis of ADHD for their child is a diagnosis for mental disease in accordance to the DSM.  Once a young    child is placed on ADHD stimulants including Adderall or Ritalin prior to ruling out causative risk factors, there is an increased health risk.   Additional medications for  the treatment of long term side effects may be required due to the development of other behavioral symptoms.   For example, the GAO drug audit uncovered a 2,200 percent increase in drug expenditures for atypical antipsychotic medication reimbursement to the state of Michigan during an eight year period from 2000 to 2008.   Children in foster care, as the report states, were abusively prescribed powerful antipsychotic medications including Abilify, Zyprexa, Seroquel, Geodon    and Risperdal.   The Michigan state Medicaid system was billed an increase of 40 million dollars during an eight year period just for this one class of medications in foster care children.   US Senator Thomas Carper,    requestor of the GAO drug audit and chairman of the Homeland Security & Government Affairs Committee, stated

"I was almost despondent to believe that the kids under the age of one, babies under age one, were receiving this kind of medication".

Should ADHD be labeled a mental disease especially in young children  who have not been given the right to find the cause of their symptoms   prior to stimulant drug therapy?   Or, should ADHD be  classified as a symptom of condition with underlying causative nutritional, physiological and environmental risk factors?

The German magazine, Der Spiegel, quoted a prominent American ADHD psychiatrist in their February 2, 2012 issue.   Dr. Leon Eisenberg, who coined the term ADHD over forty years ago, stated "ADHD is a prime example of a fictitious disease".   At age 87, this was Dr. Eisenberg's last interview prior to his death.   During the last forty years, he was involved   in pharmaceutical trials, research, teaching as well  as the development of social policy pertaining to child psychiatry.   He was a recipient of the Ruane   Prize for Child and Adolescent Psychiatry Research.   Currently,  over fifty percent of psychiatrists on the DSM panel responsible for ADHD diagnosing and treatment protocols have direct business ties to drug manufacturing corporations.  

Dr. Thomas Insel, Director of National Institute of Mental Health, stated on April 29, 2013 "patients  with behavioral conditions deserve better".the current assessment process lacks validity".   He   supports research that better treats and may even prevent the development of behavioral symptoms   in children.   ADHD symptoms can be reversed through a process of differential diagnosing.   The elimination of nutritional, physiological and environmental risk factors prior to premature drug    therapy is the new ADHD Business Model for helping children and adults reclaim their behavioral and mental health.   The Action Plan for Childhood Behavioral Conditions discussed in the book Over Medicating Our Youth as well as the upcoming 2nd edition the American Epidemic: Solutions for    Over Medicating Our Youth provides critical bio-assessment information to find the cause of ADHD symptoms.   This action plan provides an informational template to unite parents, teachers as well as all healthcare professionals for the purpose of helping children win the battle against behavioral challenges.

Many assessments help determine the cause of ADHD symptoms.  Visit the Michigan non-profit Coalition Against Overmedicating Our Youth (CAOOY)   www.CAOOY.org .   Preview the new book  release and CAOOY Educational DVD.   Learn how bio-assessments for reactive hypoglycemia, diabetes,    the Brain-gut connection, cervical spinal alignment, exercise, whole food nutrition, Brainwave Optimization and nutritional enzyme supplementation may reverse ADHD symptoms.   Stay tuned for the next Over Medicating Our Youth Business Report on Rob Kall's media network.   Understand why these assessments are needed to reduce "academic doping" at schools and colleges in America.   Help support the non-profit CAOOY movement".give children a voice to be heard across America for a positive change in The Price of ADHD Business.                                      

 

View Ratings | Rate It

- Director, Clinical Pharmacy Operations at BCOM Psychiatric Hospital in Warren, MI
- Over 25 years experience specializing in ADD stimulant and psychiatric medications
- Expert Medication & ADHD Advisor
- Educated at Wayne (more...)
 

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon



Go To Commenting
The views expressed in this article are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Writers Guidelines

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

The Price of ADHD Business (3386 views)

A Mother's Auto-antibodies: Indicator for autism and ADHD (2592 views)

Total Views: 5978